ANDA 86948, held by Watson Labs. Chlorzoxazone.
As of Nov 15, 2026, ANDA 86948 (Chlorzoxazone), held by Watson Labs, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorzoxazone250MG ยท tablet;oral | Chlorzoxazone | Discontinued |
| Aug 19, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Apr 15, 1985 | Supplement 3Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
